We’re restoring the true meaning of healthcare—developing advanced treatments and smarter and less invasive solutions for today’s most complex diseases. See how we're connecting the best of Health&Care for every patient and provider. https://lnkd.in/eW-mXA49
About us
At Johnson & Johnson Innovative Medicine, we are leading where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK
- Website
-
https://www.janssen.com/johnson-johnson-innovative-medicine
External link for Johnson & Johnson Innovative Medicine
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Type
- Privately Held
Employees at Johnson & Johnson Innovative Medicine
Updates
-
Our deep understanding of the coagulation cascade is guiding our exploration of Factor XIa inhibition in collaboration with Bristol Myers Squibb. Together, our goal is to help minimize bleeding and lower the risk of stroke for patients living with thrombotic conditions. #WTDay24
-
We’re excited to share You, Me and MG with the world. This brand-new online community will tell the stories of people living with #MyastheniaGravis (MG) and raises awareness of this condition, which impacts over 82,000 people in the U.S. It’s our hope that You, Me and MG will provide a safe space for people to authentically connect with and learn from others living with MG. To learn more and join this community, visit us on Instagram: https://lnkd.in/e84GBHS8 #YouMeAndMG
-
Last week we co-hosted the “West Coast Summit: The Transformative Power of A.I. in Pharmaceutical R&D” with California Life Sciences (CLS). The day was packed with valuable insights from our expert panels who covered topics including the role A.I. plays in accelerating drug discovery, how A.I. can reduce drug development timelines, and what the investment landscape looks like for A.I. in pharmaceutical R&D. Congratulations to the Pitching A.I. for Pharmaceutical R&D QuickFire Challenge finalists: - Ability Biologics | Lindsay Blore, M.B.A., Director Program Management - Modicus Prime | Taylor Chartier, Ph.D., Chief Executive Officer, & David Vardanyan, Director of Engineering - PrecisionLife | Rowan Gardner, Co-Founder & Chief Business & Investment Officer - Synlico Inc. | Jingwei (Gavin) Lu, Ph.D., Founder & Chief Executive Officer - ThinkingNode Life Science, Inc. | Jake Lesnik, Chief Business Officer A special thank you to all that attended the program. To learn more about open QuickFire Challenges, visit - https://lnkd.in/etaadwxG
-
There is one week left to register for the next installment of our Innovation Ignited webinar series taking place on October 16. Attendees will gain insights into J&J's key priorities and future direction in precision medicine approaches in both oncology and immunology, uncovering potential collaborative opportunities between these fields. Join us to learn how founders, academics, and innovators can engage with us and ask questions directly to our expert panelists: Carolyn Cuff, Ph.D., Vice President, Immunology Translational Science, Johnson & Johnson Innovative Medicine Ricardo Attar, Ph.D., Vice President, Oncology Translational Research, Johnson & Johnson Innovative Medicine Heike Keilhack, Ph.D., C.S.O., Rome Therapeutics We hope you can attend! RSVP now: https://lnkd.in/e-SSm_zP
-
We are excited to present our groundbreaking data in gastroenterology at this week’s #UEGW2024. By leveraging our extensive knowledge and scientific expertise, we aim to provide transformative treatment options for patients worldwide living with inflammatory bowel diseases, ulcerative colitis (UC) or Crohn’s disease (CD). Discover more about our work here: https://lnkd.in/erjFets2 #JNJImmunology
-
People of all ages with autoantibody-driven neurological diseases, such as generalized myasthenia gravis (gMG), are living with symptoms that significantly impact their daily lives. At this year’s American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting, we’re sharing 25 abstracts, including 3 oral presentations, that aim to deliver on our commitment to provide additional treatment options. Learn more: https://lnkd.in/eE6wUTs2 #AANEMinSavannah #JNJImmunology #JNJNeuroscience
-
For nearly 70 years, we’ve been committed to developing and bringing transformational treatment options to the millions of people around the world living with serious mental illness. It’s people like Greyson, who was diagnosed with major depressive disorder and bipolar disorder, that inspire us to continue driving innovative solutions to address the urgent unmet needs of the mental health community. Learn more about Greyson’s story and how he overcame challenges with depressive symptoms to reclaim his passion for art: https://bit.ly/3BeqclZ #WorldMentalHealthDay #MentalHealth #JNJNeuroscience
-
Attending World ADC San Diego? Join us for ‘Targeted Therapies - Exploring ADCs with Johnson & Johnson’ on November 4 at Farmer & The Seahorse in San Diego. Our program will explore the potential of ADCs to transform the oncology treatment landscape, highlighting innovator’s perspectives as breakthrough research that requires support pours in. After the programming concludes, there will be an opportunity to enjoy our vendor showcase and connect with our expert speakers and fellow attendees in a networking session. RSVP to secure your spot: https://lnkd.in/epVKq-_4
-
This #WorldSightDay, we join the International Agency for the Prevention of Blindness (IAPB) to recognize the importance of eye health for people of all ages. Our team is committed to supporting those with vision loss due to blinding #RetinalDiseases. We continue to work to make a difference for patients everywhere: https://bit.ly/3BBHh9n #JNJSpecialtyOphthalmology #BlindnessAwarenessMonth